Moolec Science (MLEC) Dividends Paid - Common (2023 - 2024)

Moolec Science (MLEC) reported Dividends Paid - Common of -$72051.0 for Q4 2024, up 52.48% on a YoY basis from -$47253.8 in Q1 2024, and up 52.48% sequentially from -$151612.0 in Q4 2023.

Moolec Science (MLEC) Dividends Paid - Common (2023 - 2024) Analysis & Trends

Moolec Science (MLEC) has 2 years of Dividends Paid - Common data on file, last reported at -$72051.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 97.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Moolec Science 5.35 Bn 5.35 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -72,051.00
Dec 31, 2024 -72,051.00
Dec 31, 2023 -151,612.00
Dec 31, 2023 -151,612.00